Neurofibromatosis type 2ASTHAGIRI, Ashok R; PARRY, Dilys M; BUTMAN, John A et al.Lancet (British edition). 2009, Vol 373, Num 9679, pp 1974-1986, issn 0140-6736, 13 p.Article

Molecular biology of neurofibromatosis 2 and related conditionsNUNES, Fabio; AHRONOWITZ, Iris; MACCOLLIN, Mia et al.Recent research developments in molecular & cellular biology (Vol. 5 (2004)). Recent research developments in molecular & cellular biology. 2004, pp 171-196, isbn 81-7736-213-5, 26 p.Book Chapter

Constitutional rearrangements of chromosome 22 as a cause of neurofibromatosis 2TSILCHOROZIDOU, T; MENKO, F. H; BROWN, A et al.Journal of medical genetics. 2004, Vol 41, Num 7, pp 529-534, issn 0022-2593, 6 p.Article

Earliest clinical manifestations and natural history of Neurofibromatosis type 2 (NF2) in childhood: A study of 24 patientsRUGGIERI, M; IANNETTI, P; POLIZZI, A et al.Neuropediatrics. 2005, Vol 36, Num 1, pp 21-34, issn 0174-304X, 14 p.Article

Hearing and facial function outcomes for-neurofibromatosis 2 clinical trialsPLOTKIN, Scott R; ARDERN-HOLMES, Simone L; BARKER, Fred G et al.Neurology. 2013, Vol 81, Num 21, issn 0028-3878, S25-S32, SUP1Article

Spontaneous regression of vestibular schwannomas after resection of contralateral tumor in neurofibromatosis Type 2VON ECKARDSTEIN, Kajetan L; BEATTY, Charles W; DRISCOLL, Colin L. W et al.Journal of neurosurgery. 2010, Vol 112, Num 1, pp 158-162, issn 0022-3085, 5 p.Article

The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2BASER, M. E; KURAMOTO, L; PAPI, L et al.Journal of medical genetics. 2005, Vol 42, Num 7, pp 540-546, issn 0022-2593, 7 p.Article

Correlation of Nonsense and Frameshift Mutations With Severity of Retinal Abnormalities in Neurofibromatosis 2FEUCHT, Matthias; KLUWE, Lan; MAUTNER, Victor-Felix et al.Archives of ophthalmology (1960). 2008, Vol 126, Num 10, pp 1376-1380, issn 0003-9950, 5 p.Article

Neurofibromatosis 2: A Novel Risk Factor for Hypertension?HORNIGOLD, Rachael E; GOLDING, John F; FERNER, Robin E et al.American journal of medical genetics. Part A. 2011, Vol 155, Num 7, pp 1721-1722, issn 1552-4825, 2 p.Article

Auditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2TRAN BA HUY, Patrice; KANIA, Romain; FRACHET, Bruno et al.Acta oto-laryngologica. 2009, Vol 129, Num 9, pp 971-975, issn 0001-6489, 5 p.Article

Intramedullary tumours in patients with neurofibromatosis type 2 : MRI features associated with a favourable prognosisRENNIE, A. T. M; SIDE, L; KERR, R. S. C et al.Clinical radiology. 2008, Vol 63, Num 2, pp 193-200, issn 0009-9260, 8 p.Article

Contiguous conventional and plexiform schwannomas : Report of two casesWHITE, J. Bradley; SCHEITHAUER, Bernd W; AMRAMI, Kimberly K et al.Journal of neurosurgery. 2006, Vol 104, Num 2, pp 319-324, issn 0022-3085, 6 p.Article

Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene functionSURACE, Ezequiel I; HAIPEK, Carrie A; GUTMANN, David H et al.Oncogene (Basingstoke). 2004, Vol 23, Num 2, pp 580-587, issn 0950-9232, 8 p.Article

Use of a closed set questionnaire to measure primary and secondary effects of neurofibromatosis type 2NEARY, W. J; HILLIER, V. F; FLUTE, T et al.Journal of laryngology and otology. 2010, Vol 124, Num 7, pp 720-728, issn 0022-2151, 9 p.Article

THREE-DIMENSIONAL VOLUMETRICS FOR TRACKING VESTIBULAR SCHWANNOMA GROWTH IN NEUROFIBROMATOSIS TYPE II. CommentaryHARRIS, Gordon J; PLOTKIN, Scott R; POLLOCK, Bruce E et al.Neurosurgery. 2008, Vol 62, Num 6, pp 1314-1320, issn 0148-396X, 7 p.Article

News on the genetics, epidemiology, medical care and translational research of SchwannomasHANEMANN, C. O; EVANS, D. G.Journal of neurology. 2006, Vol 253, Num 12, pp 1533-1541, issn 0340-5354, 9 p.Article

Inhibition of MEK Pathway in Vestibular Schwannoma Cell CultureNEFF, Brian A; VOSS, Stephen G; SCHMITT, William R et al.The Laryngoscope. 2012, Vol 122, Num 10, pp 2269-2278, issn 0023-852X, 10 p.Article

The molecular biology and novel treatments of vestibular schwannomas: A reviewFONG, Brendan; BARKHOUDARIAN, Garni; PEZESHKIAN, Patrick et al.Journal of neurosurgery. 2011, Vol 115, Num 5, pp 906-914, issn 0022-3085, 9 p.Article

Further genotype-phenotype correlations in neurofibromatosis 2SELVANATHAN, S. K; SHENTON, A; FERNER, R et al.Clinical genetics. 2010, Vol 77, Num 2, pp 163-170, issn 0009-9163, 8 p.Article

Validation of the p21-Activated Kinases as Targets for Inhibition in Neurofibromatosis Type 2CHUNLING YI; WILKER, Erik W; YAFFE, Michael B et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 19, pp 7932-7937, issn 0008-5472, 6 p.Article

Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: An analysis of tumor control, complications, and hearing preservation rates. CommentaryMATHIEU, David; KONDZIOLKA, Douglas; NARAYANA, Ash et al.Neurosurgery. 2007, Vol 60, Num 3, pp 460-470, issn 0148-396X, 11 p.Article

Meningioangiomatosis associated with neurofibromatosis : report of 2 cases in a single family and review of the literatureOMEIS, Ibrahim; HILLARD, Virany Huynh; BRAUN, Alex et al.Surgical neurology. 2006, Vol 65, Num 6, pp 595-603, issn 0090-3019, 9 p.Article

Treatment of schwannomas with an oncolytic recombinant herpes simplex virus in murine models of neurofibromatosis type 2MESSERLI, Shanta M; PRABHAKAR, Shilpa; YI TANG et al.Human gene therapy. 2006, Vol 17, Num 1, pp 20-30, issn 1043-0342, 11 p.Article

Unilateral vestibular schwannoma with other neurofibromatosis Type 2-related tumors : clinical and molecular study of a unique phenotypeAGHI, Manish; KLUWE, Lan; WEBSTER, Micah T et al.Journal of neurosurgery. 2006, Vol 104, Num 2, pp 201-207, issn 0022-3085, 7 p.Article

Methodological issues in longitudinal studies : vestibular schwannoma growth rates in neurofibromatosis 2BASER, M. E; MAUTNER, V.-F; PARRY, D. M et al.Journal of medical genetics. 2005, Vol 42, Num 12, pp 903-906, issn 0022-2593, 4 p.Article